Wells Fargo & Company Cumberland Pharmaceuticals Inc Transaction History
Wells Fargo & Company
- $433 Billion
- Q4 2024
A detailed history of Wells Fargo & Company transactions in Cumberland Pharmaceuticals Inc stock. As of the latest transaction made, Wells Fargo & Company holds 250 shares of CPIX stock, worth $1,287. This represents 0.0% of its overall portfolio holdings.
Number of Shares
250
Previous 250
-0.0%
Holding current value
$1,287
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding CPIX
# of Institutions
22Shares Held
1.84MCall Options Held
44.2KPut Options Held
0-
Jim Simons Renaissance Technologies LLC | New York, Ny507KShares$2.61 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA374KShares$1.93 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX273KShares$1.41 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA188KShares$969,0440.0% of portfolio
-
Bridgeway Capital Management, LLC Houston, TX184KShares$948,3980.01% of portfolio
About CUMBERLAND PHARMACEUTICALS INC
- Ticker CPIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 14,661,900
- Market Cap $75.5M
- Description
- Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, rheumatology, and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen ...